Trials / Sponsors / UCB Japan Co. Ltd.

UCB Japan Co. Ltd.

Industry · 14 registered clinical trials.

Status	Trial	Phase	Started
Completed	A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Sub Partial Seizures	Phase 3	2017-11-30
Completed	Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onse Epilepsy, Partial-onset Seizures	Phase 3	2014-06-01
Completed	A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Pa Epilepsy, Partial-onset Seizures	Phase 3	2014-04-01
Completed	Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males Healthy Volunteers	Phase 1	2012-10-01
Completed	An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy Epilepsy, Partial Onset Seizures	Phase 3	2011-12-01
Completed	Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Fact Rheumatoid Arthritis	Phase 2	2011-10-01
Completed	An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures Epilepsy, Partial Onset Seizures	Phase 2	2011-07-01
Completed	A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures Epilepsy, Generalized Tonic-clonic Seizures	Phase 3	2011-02-01
Completed	A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic S Epilepsy, Generalized Tonic-Clonic Seizures	Phase 3	2010-10-01
Completed	An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures Epilepsy, Partial Seizures	Phase 3	2010-01-01
Completed	A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Sei Epilepsies, Partial	Phase 3	2006-07-01
Completed	Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease Crohn's Disease	Phase 2	2006-05-01
Completed	A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures Epilepsies, Partial	Phase 3	2005-11-01
Completed	Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method Epilepsy, Partial	Phase 3	2001-09-12